Engineered EVs carrying overexpression plasmids for ataxia-telangiectasia and Rad3-related protein (ATR) reduced DNA damage-induced NPC senescence and inhibited the cGAS/STING pathway, effectively attenuating IVDD progression. This evidence concerns the gene ATR and nasopharyngeal carcinoma.